Egle Therapeutics

Description: Egle Therapeutics develops first-in-class immunotherapies targeting Tregs for oncology & autoimmune diseases, based in Paris.

Country: France

Based in: Paris

Founded: 2020

Funding Stage: Pre-Seed

Tags: ['Biotechnology', 'Health Care', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.